Visualized clinical-radiomics model for predicting the efficacy of surufatinib in hepatic metastases of neuroendocrine neoplasms
{{output}}
Background: Hepatic metastatic neuroendocrine neoplasms (HM-NENs) have few treatment biomarkers and low survival rates. We created a clinical-radiomics fusion model to predict surufatinib efficacy in HM-NENs and presented it as a... ...
